longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Atlantic

ATLN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.89, within the reasonable range, cheaper than 33.72% of the time in the past 1 years, and the industry ranks 27/59, the industry Median -1.56.

-0.895xP/E
--Stock price
-0.895xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.53x
Typical range
-2.10x–-0.89x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-350.37x--$48.28B
TEMUSTempus AI
-59.94x1.23%$15.25B
CRLUSCharles River Laboratorie
-58.63x229.32%$13.98B
TXGUS10X Genomics
-148.65x107.32%$11.17B
AVTRUSAvantor
-17.85x142.83%$10.31B
BRKRUSBruker
-91.47x7.71%$9.78B
ADPTUSAdaptive Biotechnologies
-73.56x39.98%$4.70B
ABCLUSAbcellera Biologics
-24.99x34.69%$4.12B
ALMRUSAlamar Biosciences
-45.83x80.55%$2.28B
MRVIUSMaravai LifeSciences
-25.50x65.83%$1.97B
FTREUSFortrea
-22.20x93.77%$1.89B
PSNLUSPersonalis
-16.40x20.05%$1.76B
AZTAUSAzenta
-12.13x180.77%$1.49B
CYRXUSCryoport
-19.43x156.25%$881.80M
CTKBUSCytek Biosciences
-9.11x33.98%$734.41M
DNAUSGinkgo Bioworks
-2.47x35.20%$717.85M
OABIUSOmniAb
-15.14x35.96%$670.25M
EVOUSEvotec SE
-2.42x381.02%$554.13M
PACBUSPacific Biosc California
-3.83x75.82%$503.55M
TKNOUSAlpha Teknova
-29.87x5.80%$500.91M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.